LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.54 | 17.25 | 1256 | 2679 | 0.4687 | 0.8023 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.51 | 17.25 | 411 | 2906 | 0.1414 | 0.5353 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.51 | 17.25 | 1473 | 2906 | 0.5069 | 0.8244 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.51 | 17.25 | 6 | 2906 | 0.0021 | -0.1331 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.51 | 17.25 | 1257 | 2906 | 0.4325 | 0.7857 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.48 | 17.25 | 477 | 3125 | 0.1526 | 0.5567 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.48 | 17.25 | 1535 | 3125 | 0.4911 | 0.8191 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.48 | 17.25 | 6 | 3125 | 0.0019 | -0.1313 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.48 | 17.25 | 1283 | 3125 | 0.4105 | 0.7761 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 42.45 | 17.25 | 546 | 3504 | 0.1558 | 0.5693 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 42.45 | 17.25 | 1611 | 3504 | 0.4598 | 0.8072 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 42.45 | 17.25 | 6 | 3504 | 0.0017 | -0.1287 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 42.45 | 17.25 | 1345 | 3504 | 0.3838 | 0.7652 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 44.42 | 17.25 | 614 | 3895 | 0.1576 | 0.5791 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 44.42 | 17.25 | 1662 | 3895 | 0.4266 | 0.7936 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 44.42 | 17.25 | 5 | 3895 | 0.0013 | -0.1465 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 44.42 | 17.25 | 1440 | 3895 | 0.3696 | 0.7610 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.39 | 17.25 | 703 | 4141 | 0.1697 | 0.5982 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.39 | 17.25 | 1768 | 4141 | 0.4269 | 0.7959 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.39 | 17.25 | 6 | 4141 | 0.0014 | -0.1250 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 46.39 | 17.25 | 1462 | 4141 | 0.3530 | 0.7532 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 48.36 | 17.25 | 1187 | 4390 | 0.2704 | 0.6980 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 48.36 | 17.25 | 1832 | 4390 | 0.4173 | 0.7928 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 48.36 | 17.25 | 8 | 4390 | 0.0018 | -0.0917 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 48.36 | 17.25 | 1617 | 4390 | 0.3683 | 0.7650 | MN20160310_N02 | N22 |